MFDS
- Status: likely_approved
🇰🇷 Persantine in South Korea
Persantine (DIPYRIDAMOLE) regulatory status in South Korea.
Marketing authorisation
Persantine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in South Korea
Frequently asked questions
Is Persantine approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Persantine in South Korea?
Boehringer Ingelheim is the originator. The local marketing authorisation holder may differ — check the official source linked above.